Shaping the Future of Nanomedicine Metrology Together.
Dear Colleagues and Nanomedicine Enthusiasts,
We are excited to announce the launch of the METRINO Survey on Clinical Nanomedicine, following the success of our initial survey focused on Reference Materials and standard test methods in nanomedicine. This new survey specifically targets the realm of clinical nanomedicine, and we need your vital insights.
Your unique expertise as clinicians, scientists, and professionals involved in ADME, biodistribution, and pharmacokinetic studies of nanomedicine is pivotal. The insights from your frontline experiences in working with formulations such as liposomes, metal oxides, and lipid-based nanoparticles for RNA delivery will guide the METRINO project in selecting the most relevant nanoparticles, cell lines, tissues, and dosages. This survey is a direct channel for you to influence the future actions of the European Metrology community and contribute to a field that has the potential to revolutionize patient outcomes.
In this survey, we explore several critical areas, and you can answer to all or only some of these improtant topics:
Your responses are confidential and will be used exclusively within the METRINO project. We respect your privacy and guarantee no disclosure of your information without explicit consent.
Connect with Us
For any questions or additional information, feel free to contact us:
Your time and expertise are highly valued, and we thank you in advance for your contribution to this significant endeavor.
Together, we can drive innovation and enhance patient care in the field of nanomedicine.
Warm regards,
The METRINO Team
The METRINO project has received funding from the European Partnership on Metrology (Grant #22HLT04), co-financed from the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EURAMET. Neither the European Union nor the granting authority can be held responsible for them.